Melanotan-1 · Research brief

How to Read Melanotan-1 COA — Lab Analysis Decoded

Q: What does HPLC purity percentage actually measure in a melanotan-1 COA?

HPLC purity quantifies the percentage of melanotan-1 relative to all peptide content in the sample by measuring area under the curve on a chromatogram. A purity of 98% means melanotan-1 accounts for 98% of total peptide mass, with the remaining 2% comprising truncated sequences, deletion peptides, and synthesis byproducts. HPLC separates compounds based on how they interact with a stationary phase under pressure — melanotan-1 elutes at a specific retention time, and impurities elute at different times, producing distinct peaks that are integrated to calculate relative abundance.

Q: Can I trust a melanotan-1 COA that does not include the HPLC chromatogram image?

No — a COA without the chromatogram is incomplete and potentially fabricated. The chromatogram is the primary evidence supporting the stated purity percentage, showing baseline, peaks, retention time, and area integration. Legitimate testing labs provide chromatograms as standard documentation because the raw data is what validates the numerical purity claim. Suppliers who omit chromatograms either did not commission genuine third-party testing or are hiding data that contradicts their purity claims.

Q: What is an acceptable bacterial endotoxin level for research-grade melanotan-1?

Research-grade melanotan-1 must test below 5 EU/mg (endotoxin units per milligram) via LAL assay. Endotoxin levels above 10 EU/mg cause pyrogenic reactions — fever, inflammation, immune activation — in cell culture and animal models, rendering the peptide unsuitable for biological applications. Endotoxins are lipopolysaccharide fragments from gram-negative bacteria that survive standard sterilization; their presence indicates contamination during synthesis or lyophilization that was not adequately controlled.

Q: How do I verify that the testing lab listed on a melanotan-1 COA is legitimate?

Cross-reference the lab’s name and accreditation claim with ISO’s public database of accredited testing facilities. ISO 17025 accreditation is mandatory for pharmaceutical-grade analytical labs — it confirms calibrated equipment, validated methods, and trained personnel. Contact the lab directly using contact information from their official website (not the COA) and request confirmation that they performed analysis for the specific batch number. Legitimate labs will confirm or deny without violating client confidentiality; fabricated COAs list labs that either don’t exist or never performed the claimed testing.

Q: What does it mean if the molecular weight on the COA does not match the expected value for melanotan-1?

A molecular weight discrepancy greater than ±1 Da from the expected 1646.85 Da indicates the peptide structure is incorrect — either a synthesis error (wrong amino acid substitution, deletion, or truncation) or the vial was mislabeled and contains a different compound entirely. Mass spectrometry confirms peptide identity by measuring the mass-to-charge ratio of ionized molecules. Small deviations within 1 Da are acceptable due to instrument precision limits, but discrepancies of 2 Da or more mean the compound is not melanotan-1.

Q: Why do some melanotan-1 COAs omit endotoxin testing entirely?

Endotoxin testing is omitted by budget suppliers as a cost-cutting measure — LAL assays cost $150–300 per batch, and peptide vendors targeting price-sensitive researchers skip this step to maintain lower pricing. The absence of endotoxin data does not mean the peptide is clean; it means contamination status is unknown. Research-grade peptides intended for biological applications require quantified endotoxin levels below 5 EU/mg, and COAs that report only ‘passes sterility’ without LAL assay results are incomplete documentation.

Q: What should I do if the batch number on my melanotan-1 vial does not match the batch number on the COA?

Do not use the peptide — return it or request corrected documentation. Batch traceability is the only mechanism that ties third-party analytical data to the physical vial you received. A mismatch means the COA represents a different production run, or the vial was mislabeled after testing, both of which introduce unknown contamination risk and invalidate any experimental results. Reputable suppliers provide batch-specific COAs with lot numbers that match vial labels exactly; mismatches indicate poor quality control or deliberate mislabeling.

Q: How often should melanotan-1 batches be retested if stored long-term?

Lyophilized melanotan-1 stored at −20°C remains stable for 12–24 months, but degradation accelerates if temperature excursions occur or the vial is opened repeatedly. Retest purity via HPLC after 12 months of storage or after any temperature excursion above 8°C lasting more than 48 hours. Reconstituted melanotan-1 degrades within 28 days even under refrigeration; any reconstituted solution older than 4 weeks should be discarded regardless of appearance, as peptide fragmentation occurs before visible discoloration.

Q: What is the difference between sterility testing and endotoxin testing in a melanotan-1 COA?

Sterility testing confirms no viable bacteria or fungi remain in the peptide after lyophilization, typically via 14-day incubation per USP standards. Endotoxin testing via LAL assay detects residual bacterial lipopolysaccharide fragments that survive sterilization — these are not live organisms but heat-stable contaminants that trigger immune responses. Both tests are required because a peptide can pass sterility (no live bacteria) but still contain high endotoxin levels from bacteria killed during synthesis, and endotoxins cause pyrogenic reactions even in the absence of viable organisms.

Real Peptides Research TeamEditorial

Updated July 9, 20269 min read

57 WORDS

Short answer

Most melanotan-1 batches fail at less than 90% purity. But researchers ordering online wouldn't know that without a COA. A Certificate of Analysis isn't marketing material; it's independent lab verification that the peptide you received matches the chemical structure, purity, and safety profile claimed by the supplier. The gap between 98% purity and 85% purity isn't cosmetic.

Key takeaways

A legitimate melanotan-1 COA includes the testing lab's name, physical address, ISO 17025 accreditation, and a batch number that matches your vial label.
HPLC purity above 95% is standard for research-grade peptides; anything below 90% indicates synthesis problems or storage degradation.
Mass spectrometry confirms molecular weight within ±1 Da of the expected 1646.85 Da for melanotan-1. Discrepancies greater than 2 Da mean the peptide structure is incorrect.
Bacterial endotoxin levels must be quantified below 5 EU/mg via LAL assay; COAs that omit endotoxin testing or report only 'passes sterility' are incomplete.
A COA without the HPLC chromatogram image is almost always fabricated. Legitimate labs provide the raw data showing peaks, retention time, and area integration.
Batch traceability is non-negotiable: the COA must reference the specific lot number printed on your peptide vial, not a generic analysis.

Our team has reviewed thousands of peptide COAs over years of supplying research-grade compounds. The difference between a legitimate COA and a fabricated one comes down to three things most researchers don't know to look for: the analytical method used, the accreditation of the testing lab, and the specific contaminant thresholds reported.

How do you read melanotan-1 COA correctly?

A melanotan-1 COA confirms peptide identity, purity percentage, and absence of bacterial endotoxins through third-party HPLC and mass spectrometry analysis. Purity above 95% is standard for research-grade material; endotoxin levels below 5 EU/mg are required for sterile applications. Red flags include missing batch numbers, unnamed testing labs, or purity reported without accompanying chromatograms.

Most COAs you'll encounter online are formatted correctly but lack substance. A legitimate COA doesn't just state 'purity: 98%'. It shows the chromatogram that produced that number, names the HPLC column used, and specifies retention time. This article covers how HPLC quantifies peptide purity, what bacterial endotoxin testing measures, and which missing data points indicate a supplier fabricated the document rather than commissioning genuine third-party analysis.

Step 1: Verify the Testing Lab Identification Block

Every legitimate COA begins with a laboratory identification block. The institution that performed the analysis, its physical address, and its accreditation status. Peptide purity testing requires ISO 17025 accreditation, which confirms the lab's equipment is calibrated, methods are validated, and staff are trained to pharmaceutical-grade standards. An unnamed 'independent lab' or a testing facility without verifiable address or accreditation is a red flag that the COA may not represent actual testing.

The identification block should include the testing lab's name, physical location, accreditation body (ISO 17025 or equivalent), and the date of analysis. Cross-reference the lab's name with public accreditation databases. ISO maintains a searchable directory of accredited labs worldwide. If the lab name returns no results or the accreditation claim cannot be verified, the COA's legitimacy is questionable.

Batch traceability ties the specific vial in your hands to the exact sample tested. Every COA must list a unique batch or lot number that matches the label on your peptide vial. Without batch-specific identification, the COA could represent any production run. Or no production run at all. When you learn to read melanotan-1 COA documentation from Real Peptides, that batch number links directly to third-party HPLC chromatograms archived by accredited facilities.

Step 2: Interpret HPLC Purity Quantification and Chromatogram Data

HPLC (High-Performance Liquid Chromatography) is the analytical method that quantifies peptide purity. It separates the target peptide from impurities based on how each molecule interacts with a stationary phase under pressure. A melanotan-1 sample is dissolved and passed through a column packed with microscopic silica beads; melanotan-1 elutes (exits) at a specific retention time based on its molecular structure, while truncated peptides, deletion sequences, and residual synthesis byproducts elute at different times.

The chromatogram. The graphical output of HPLC. Shows peaks along a time axis. The tallest peak represents melanotan-1; smaller peaks represent impurities. Purity percentage is calculated as the area under the melanotan-1 peak divided by the total area under all peaks. A COA stating '98.2% purity' means melanotan-1 accounts for 98.2% of the total peptide content by area under the curve. Research-grade peptides require purity above 95%; anything below 90% indicates synthesis problems or degradation during storage.

Mass spectrometry confirmation runs parallel to HPLC. While HPLC measures purity, mass spec verifies molecular weight. Confirming that the primary peak is actually melanotan-1 (molecular weight 1646.85 Da) rather than a structurally similar contaminant. The COA should list the expected molecular weight and the observed molecular weight from the sample. A discrepancy greater than ±1 Da suggests the peptide structure is incorrect. Either a synthesis error or mislabeling.

Our experience shows that COAs without accompanying chromatograms are almost always fabricated. A legitimate testing lab provides the raw data. The chromatogram image showing baseline, peaks, retention time, and area integration. If the COA lists purity as a single number without the chromatogram that generated it, that document has not been verified.

Step 3: Assess Bacterial Endotoxin Testing and Sterility Confirmation

Bacterial endotoxins. Lipopolysaccharide fragments from gram-negative bacteria. Are the most dangerous contaminant in synthetic peptides because they trigger immune responses even at sub-microgram levels. Endotoxins survive standard sterilization (they are heat-stable up to 250°C), so their presence indicates contamination during synthesis or lyophilization. The LAL (Limulus Amebocyte Lysate) assay quantifies endotoxin concentration; research-grade peptides must test below 5 EU/mg (endotoxin units per milligram).

A COA for melanotan-1 should list endotoxin levels explicitly. Not just 'passes sterility' or 'meets USP standards'. The numerical threshold matters. Endotoxin concentrations above 10 EU/mg cause pyrogenic reactions (fever, inflammation) in cell culture models and animal studies; above 50 EU/mg, the peptide is unusable for any biological application. If the COA omits endotoxin testing entirely or reports only 'negative' without a quantitative measurement, that batch was not tested to pharmaceutical standards.

Sterility confirmation via microbial testing ensures no viable bacteria or fungi remain in the lyophilized powder. This is distinct from endotoxin testing. Sterility confirms absence of live organisms, while LAL assay detects residual bacterial fragments. Both tests are required for research-grade peptides. The COA should state 'no growth observed' after 14-day incubation per USP <71> sterility standards.

Our team has found that suppliers who skip endotoxin testing are cutting costs. LAL assays cost $150–300 per batch, and many budget peptide vendors omit this step entirely. When you read melanotan-1 COA documentation from a reputable source, endotoxin quantification is non-negotiable.

How to Read Melanotan-1 COA: Testing Method Comparison

Testing Method	What It Measures	Acceptable Range	Red Flag Threshold	Professional Assessment
HPLC Purity	Percentage of target peptide vs impurities	≥95% for research-grade	<90% indicates degradation or poor synthesis	HPLC is the gold standard for purity quantification. Any COA without HPLC data is incomplete
Mass Spectrometry	Molecular weight confirmation	Expected MW ± 1 Da	Discrepancy >2 Da means wrong peptide or structural error	Mass spec verifies identity. HPLC alone cannot distinguish structurally similar peptides
LAL Endotoxin Assay	Bacterial endotoxin concentration	<5 EU/mg for research use	>10 EU/mg causes pyrogenic effects in cell culture	Endotoxin testing is often omitted by budget suppliers. Its absence is the single clearest cost-cutting signal
Microbial Sterility	Presence of viable bacteria or fungi	No growth after 14 days	Any detectable growth disqualifies the batch	Sterility confirms no live contamination. Distinct from endotoxin testing which detects residual fragments
Amino Acid Analysis	Sequence confirmation	100% match to expected sequence	Any substitution or deletion invalidates the peptide	AA analysis is optional for routine batches but mandatory when HPLC or mass spec shows anomalies

What If: Melanotan-1 COA Scenarios

What If the COA Shows 92% Purity Instead of 98%?

Order a replacement batch. Purity below 95% falls outside research-grade standards and introduces uncontrolled variables that compromise reproducibility. The 8% impurity fraction contains truncated peptides, deletion sequences, and residual synthesis reagents. Each with unknown biological activity that confounds your experimental results. Reputable suppliers replace substandard batches at no cost because 92% purity represents a synthesis or storage failure, not acceptable variation.

What If the Testing Lab Listed on the COA Has No Verifiable Accreditation?

Assume the COA is fabricated until proven otherwise. Cross-reference the lab's name with ISO 17025 accreditation databases; if the lab does not appear or the accreditation cannot be verified through a third party, the document may be a generic template rather than a genuine analysis. Contact the testing lab directly using contact information from their official website. Not the contact details listed on the COA. And request confirmation that they performed the analysis for that batch number. Legitimate labs maintain client confidentiality but will confirm whether a specific COA originated from their facility.

What If the Batch Number on My Vial Doesn't Match the Batch Number on the COA?

Do not use the peptide. Batch traceability is the only mechanism that ties the COA's analytical data to the physical vial in your possession. A mismatch means the COA represents a different production run. Or the vial was mislabeled after testing. Either scenario introduces unknown contamination risk and invalidates any experimental data generated. Request a corrected COA from the supplier with documentation proving the vial's batch was tested, or return the product for a replacement with matching documentation.

The Unfiltered Truth About Melanotan-1 COA Documentation

Here's the honest answer: most peptide suppliers online provide COAs that look professional but represent no actual third-party testing. The document includes all the right headings. 'Purity: 98.5%', 'Endotoxin: <5 EU/mg', 'Mass Spec: Confirmed'. But no chromatogram, no accredited lab name, and no verifiable batch traceability. These are template COAs generated in-house, formatted to pass a visual inspection but containing no independently verified data.

The tell is the absence of the chromatogram image. HPLC analysis produces a graphical output showing every peak detected in the sample. A lab that performed genuine HPLC testing provides that chromatogram because it's the primary evidence supporting the purity claim. Suppliers who fabricate COAs cannot include the chromatogram because they didn't run the test. So they omit it and hope researchers don't notice. If you cannot see the peaks, retention time, and baseline integration that generated the stated purity percentage, the COA is decorative, not evidential.

Another red flag: COAs with identical formatting across multiple batches and peptides, showing suspiciously consistent purity values (always 98.2%, never 96.8% or 99.1%). Real analytical data varies slightly between batches because synthesis and lyophilization introduce minor stochastic variation. When every COA from a supplier shows the same purity to the first decimal place, those numbers were typed, not measured.

When you read melanotan-1 COA documentation from Real Peptides, you're reviewing third-party HPLC chromatograms generated by ISO-accredited facilities with verifiable batch-specific data. The difference between a legitimate COA and a fabricated one is evidence. And evidence lives in the chromatogram.

The peptide research field operates with minimal oversight compared to pharmaceutical manufacturing, and many suppliers exploit that gap by providing documentation that looks authoritative but proves nothing. The onus falls on researchers to verify what they're working with. Because no regulatory body is checking. Learning to read melanotan-1 COA data correctly is not optional; it's the minimum diligence required before introducing any compound into a controlled experimental system.

If the COA you received omits the chromatogram, lacks verifiable lab accreditation, or shows batch numbers that don't match your vial label. Request corrected documentation or source from a supplier who treats analytical verification as non-negotiable rather than a checkbox to fill.

References

Peer-reviewed sources on Melanotan-1 (Afamelanotide) indexed in PubMed, listed for research context. Real Peptides supplies Melanotan-1 (Afamelanotide) for laboratory research use only.

Afamelanotide in protoporphyria and other skin diseases: a review. Postepy dermatologii i alergologii, 2024. PMID 38784937. doi:10.5114/ada.2024.138818
Afamelanotide: A Review in Erythropoietic Protoporphyria. American journal of clinical dermatology, 2016. PMID 26979527. doi:10.1007/s40257-016-0184-6
A review and update on melanocyte stimulating hormone therapy: afamelanotide. Journal of drugs in dermatology : JDD, 2013. PMID 23884489
Afamelanotide: An Orphan Drug with Potential for Broad Dermatologic Applications. Journal of drugs in dermatology : JDD, 2021. PMID 33683075. doi:10.36849/JDD.5526
Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria. Expert review of clinical pharmacology, 2021. PMID 33507118. doi:10.1080/17512433.2021.1879638
Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders. Clinical pharmacokinetics, 2017. PMID 28063031. doi:10.1007/s40262-016-0501-5
Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria. Expert review of clinical pharmacology, 2015. PMID 25470471. doi:10.1586/17512433.2014.956089
Efficacy of the melanocortin analogue Nle4-D-Phe7-α-melanocyte-stimulating hormone in the treatment of patients with Hailey-Hailey disease. Clinical and experimental dermatology, 2014. PMID 24256215. doi:10.1111/ced.12203

Questions